- Home
- PHGE vs FGF Comparison
PHGE vs FGF Comparison
Compare PHGE & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHGE
- FGF
- Stock Information
- Founded
- PHGE 2015
- FGF 2012
- Country
- PHGE Israel
- FGF United States
- Employees
- PHGE N/A
- FGF N/A
- Industry
- PHGE Biotechnology: Pharmaceutical Preparations
- FGF Property-Casualty Insurers
- Sector
- PHGE Health Care
- FGF Finance
- Exchange
- PHGE Nasdaq
- FGF Nasdaq
- Market Cap
- PHGE 26.5M
- FGF 28.0M
- IPO Year
- PHGE N/A
- FGF N/A
- Fundamental
- Price
- PHGE $0.75
- FGF $23.94
- Analyst Decision
- PHGE Strong Buy
- FGF
- Analyst Count
- PHGE 2
- FGF 0
- Target Price
- PHGE $22.50
- FGF N/A
- AVG Volume (30 Days)
- PHGE 151.9K
- FGF 36.3K
- Earning Date
- PHGE 11-14-2024
- FGF 11-22-2024
- Dividend Yield
- PHGE N/A
- FGF N/A
- EPS Growth
- PHGE N/A
- FGF N/A
- EPS
- PHGE N/A
- FGF N/A
- Revenue
- PHGE N/A
- FGF $51,021,000.00
- Revenue This Year
- PHGE N/A
- FGF N/A
- Revenue Next Year
- PHGE N/A
- FGF N/A
- P/E Ratio
- PHGE N/A
- FGF N/A
- Revenue Growth
- PHGE N/A
- FGF 29.20
- 52 Week Low
- PHGE $0.62
- FGF $14.21
- 52 Week High
- PHGE $8.55
- FGF $44.00
- Technical
- Relative Strength Index (RSI)
- PHGE 36.37
- FGF 52.45
- Support Level
- PHGE $0.67
- FGF $16.25
- Resistance Level
- PHGE $0.81
- FGF $22.58
- Average True Range (ATR)
- PHGE 0.09
- FGF 2.76
- MACD
- PHGE 0.00
- FGF 0.11
- Stochastic Oscillator
- PHGE 44.00
- FGF 54.99
About PHGE BiomX Inc. COmmon Stock
BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.
About FGF FG Financial Group Inc. (NV)
Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.